Amphastar Pharmaceuticals's total assets for Q3 2025 were $1.67B, an increase of 3.15% from the previous quarter. AMPH total liabilities were $889.48M for the fiscal quarter, a 3.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.